innovation

Pharmaceutical globalization: Where are drugs invented?

October 18, 2011

I’m back from the Filling the Pipeline conference in Boston, where I presented a talk on pharmaceutical globalization. Maintaining control of pharmaceutical drug innovation is key for national security, public health, and economic development. We know that much of late-stage development has gone overseas, but the question remains: Where are drugs invented? Using the DrugPatentWatch [...]

Read the full article →

Building Biotechnology in Turkey

July 6, 2011

The Turkish response to the innovation score I generated for them in the Scientific American Worldview Scorecard was pretty clear. They interpret their low score — 39th out of 48 countries measured — as an indication that they continue to ‘miss the biotech train.’ The primary reasons for Turkey’s low score are: Relatively weak intellectual [...]

Read the full article →

Third Annual Scientific American Worldview: Measuring Global Biotechnology

June 29, 2011

The third issue of Scientic American’s Worldview is now available at www.saworldview.com. In this latest issue I continue my comparative assessment of the biotechnology innovation environment in different countries. I also include additional highlights: Which country is home to the most drug inventors? Which country has the greatest biotechnology patenting intensity? Which country has the [...]

Read the full article →

Neglected Disease Drug Development: Incentives for Success

June 1, 2011

This paper is a final project from the NIH Foundation for Advanced Education in the Sciences TECH 366, a course in Biotechnology Management Neglected Disease Drug Development: Incentives for Success Dr. Jason Chong How are treatments being developed for neglected diseases? Historically, pharmaceutical research and development (R&D) of drugs have been driven by the private [...]

Read the full article →

Going Global: Partnering and Investing in International Life Sciences

May 25, 2011

I will be presenting in an upcoming webinar: Going Global Partnering and Investing in International Life Sciences   Today, successful life sciences companies are feverishly evaluating international partnerships in search of places that are rapidly expanding. Some make the costly mistake of only using market size as the deciding factor, which is often misleading. Success [...]

Read the full article →

Globalization of pharmaceutical innovation

March 31, 2011

Here’s a copy of the talk I gave at the American Chemical Society meeting, on using patent information to track globalization: Using patent information to track globalization Check out it. I think the findings will surprise you!

Read the full article →

Globalization in the pharmaceutical industry: Where are drugs invented?

November 1, 2010

I’ve just had a paper published in Nature Reviews Drug Discovery, using data from DrugPatentWatch to profile the locations of drug invention for the past decade. The location of drug development is important for two reasons. Firstly, it is important to track the global spread of innovation. Much late stage drug development (e.g. clinical trials) [...]

Read the full article →

Medicine for Tomorrow: An Article on Pharmaceutical Research and Development by Nobel Prize-Winning Economist Joseph Stiglitz

September 11, 2010

As stringent new budgets have led to pharmaceutical companies cutting back, a certain concern and scepticism has risen over the high prices charged by drug companies, their continued problems with productivity, and falling success rates of new drugs. A significant drop in investment in drugmaking companies, and president Obama’s recent reforms of the healthcare system [...]

Read the full article →

Coming soon – Biotechnology Entrepreneurship: From Science to Solutions

August 24, 2010

See larger image Biotechnology Entrepreneurship From Science to Solutions — Start-up, Company Formation and Organization, Team, Intellectual Property, Financing, … Regulatory Affairs, Reimbursement, Exit (Paperback) By (author) Michael L Salgaller List Price: $64.95 USD New From: $64.95 In Stock Used from: $60.99 In Stock Coming soon, a book by Michael L. Salgaller, PhD. In this [...]

Read the full article →

Drug inventor report profiles individuals, US states, and countries leading pharmaceutical innovation

August 16, 2010

A new report from DrugPatentWatch.com profiles the leading researchers, US states, and countries responsible for drugs approved over the past ten years. The report features: Top Inventors Which inventors were granted the most patents? Patents per Inventor The patents awarded to each inventor Approved Drugs per Inventor The approved drugs protected by each inventor’s patents [...]

Read the full article →

← Previous Entries